0001225208-24-002963.txt : 20240226 0001225208-24-002963.hdr.sgml : 20240226 20240226175221 ACCESSION NUMBER: 0001225208-24-002963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240223 FILED AS OF DATE: 20240226 DATE AS OF CHANGE: 20240226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALLAHUE KIERAN CENTRAL INDEX KEY: 0001308428 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 24680710 MAIL ADDRESS: STREET 1: PO BOX 684369 CITY: PARK CITY STATE: UT ZIP: 84068 FORMER NAME: FORMER CONFORMED NAME: Gallahue Kieran DATE OF NAME CHANGE: 20041110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0508 4 2024-02-23 0001099800 Edwards Lifesciences Corp EW 0001308428 GALLAHUE KIERAN ONE EDWARDS WAY IRVINE CA 92614 1 0 Common Stock 2024-02-23 4 M 0 7056.0000 36.8633 A 10757.0000 D Common Stock 2024-02-23 4 G 0 7056.0000 0.0000 D 3701.0000 D Common Stock 2024-02-23 4 G 0 7056.0000 0.0000 A 70277.0000 I By Trust Common Stock 2024-02-23 4 S 0 3058.0000 87.6100 D 67219.0000 I By Trust Director Stock Option (Right to Acquire) 36.8633 2024-02-23 4 M 0 7056.0000 0.0000 D 2017-05-12 2024-05-11 Common Stock 7056.0000 0.0000 D This transaction was executed in multiple trades at prices ranging from $87.5908 to $87.6210. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. Linda J. Park, Attorney-in-Fact 2024-02-26